Extended-Release Naltrexone/Bupropion in Patients With T2D Already on Incretin Agents
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
International Journal of Obesity (2005)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Extended-Release Naltrexone/Bupropion Is Safe and Effective Among Subjects With Type 2 Diabetes Already Taking Incretin Agents: A Post-Hoc Analysis of the LIGHT Trial
Int J Obes (Lond) 2021 Aug 01;45(8)1687-1695, S Wharton, P Yin, M Burrows, E Gould, J Blavignac, RAG Christensen, E Kamran, F Camacho, M BarakatFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.